Our research-based matching system motivates people to donate to highly effective charities at GivingMultiplier.org.

**[Giving Multiplier](https://givingmultiplier.org)** is a research project created at Harvard University that matches donations to any charity of your choice and promotes the world's most effective charities.

*Resources to get involved:*

- [Make a donation that gets matched](https://givingmultiplier.org)
- [Become a matching funder](http://givingmultiplier.org/matching) (Donations made on this page will also go toward our matching system.)
- [Sign up to our newsletter](http://eepurl.com/i0GHhc)
- [Learn about our philosophy](https://givingmultiplier.org/philosophy)
- [Create your own fundraiser](https://givingmultiplier.org/fundraisers)

Giving Multiplier

Malaria Consortium

One of GiveWell's top charities for the past several years, AMF provides anti-malarial bednets to people in need. 

From Givewell: 
What do they do? AMF (againstmalaria.com) provides funding for long-lasting insecticide-treated net (LLIN) distributions (for protection against malaria) in developing countries. (More)

Does it work? There is strong evidence that distributing LLINs reduces child mortality and malaria cases. AMF conducts post-distribution surveys of completed distributions to determine whether LLINs have reached their intended destinations and how long they remain in good condition. AMF's post-distribution surveys have generally found positive results but have some methodological limitations. (More)

What do you get for your dollar? We estimate that the cost to purchase and distribute an AMF-funded net is $4.95, or $4.65 excluding in-kind contributions from governments. The numbers of deaths averted and other benefits of distributing LLINs are a function of a number of difficult-to-estimate factors, which we discuss in detail below. (More)

Is there room for more funding? We believe that AMF is likely to be constrained by funding. We estimate that AMF could use up to an additional $37.8 million to support LLIN distributions that will occur between now and late 2023. 

AMF is recommended because of its:

Focus on a program with excellent evidence of effectiveness and cost-effectiveness.
Processes for ensuring that nets reach their intended recipients and monitoring whether they remain in homes and in good condition over the long-term.
Room for more funding – we believe AMF will be able to use additional funds to deliver additional nets.
Transparency – AMF shares significant information about its work with us and we are able to closely follow and understand its work.

The Against Malaria Foundation

Helen Keller, our co-founder, envisioned a world without barriers to human potential. We are continuing her work.


Helen Keller, our co-founder, envisioned a world without barriers to human potential. Guided by her fierce optimism, we have been working on the front lines of health and well-being for more than 100 years. We deliver life-changing health care to vulnerable families in places where the need is great, but access is limited. Our proven, science-based programs empower people to create opportunities in their own lives.


Helen Keller International

We provide cash incentives for childhood vaccinations. It’s one of the most cost-effective ways known to save lives.


New Incentives’ mission is to save lives in a way that does the **most good per dollar**.
Guided by evidence, we provide cash incentives to increase childhood vaccination rates.

- We [raise awareness](https://www.newincentives.org/blog-posts/awareness-activities) about the benefits of childhood vaccinations.
- We [provide cash incentives](https://www.newincentives.org/blog-posts/a-day-in-the-life-abubakar-aliyu-field-officer) at government clinics after children receive vaccinations.
- We [help improve the vaccine supply chain](https://www.newincentives.org/blog-posts/supporting-government-partners-with-vaccine-supply-efforts) to ensure enough vaccines are available at clinics.

Together, these efforts are proven to double vaccination rates and save lives.
Learn more about the [randomized controlled trial](https://www.newincentives.org/rct-results).

As of March 2024, New Incentives has reached more the 3 million infants in northern Nigeria.

New Incentives

Evidence Action scales evidence-based and cost-effective programs to reduce the burden of poverty. 

Evidence Action was founded in 2013 to address a big gap in the fight against global poverty – many of the most promising interventions are either implemented at a very small scale, or not at all. We set out to address this gap by building programs that would scale evidence-based and cost-effective interventions, leading to significant improvements in quality of life for hundreds of millions of people.

Our model worked. Since then, our interventions have reached more than 530 million people. This success is achieved through the dedication and talent of our staff, the hard work of our partners, and the commitment of our supporters.

Our Accelerator is the engine for our new program development. To find the most cost-effective solutions in the world, we explore untapped opportunities with the greatest potential for impact. Through a rigorous process, we test groundbreaking health and development interventions, selecting those with a proven ability to reduce the burden of poverty at scale. This focus allows us to maximize the impact made for every single dollar invested.

**Programs:**

**Safe Water Now**

We provide sustained safe water access to communities through water treatment – one of the most cost-effective ways to prevent childhood illnesses and death. Safe Water Now programming in Kenya, Uganda, Malawi, and India uses innovative, low-cost approaches like chlorine dispensers and automatic in-line chlorination. With local government and community buy-in, we reach nearly 10 million people with safe water access and have saved the lives of more than 15,000 children under 5 years old. Now, we are scaling in partnership with the Government of India to reach tens of millions more.

**Deworm the World** 

We help improve children's health, education, and long-term wellbeing by treating parasitic worm

infections at schools. In partnership with governments in Kenya, Nigeria, India, and Pakistan, Evidence Action designs, scales, and sustains cost-effective mass deworming programs. Since 2014, Deworm the World has helped governments deliver 2 billion deworming treatments to children, dramatically reducing worm prevalence and collectively increasing economic productivity by an estimated $23 billion USD.

**Equal Vitamin Access**

We combat the leading cause of childhood malnutrition and disability in low- and middle-income countries by helping to deliver essential supplementation. Equal Vitamin Access provides end-to-end support to governments in India and Malawi to address anemia by leveraging our school-based deworming platform to offer iron and folic acid supplementation cost effectively. In 2023 alone, our program reached 35.8 million children with weekly treatments, giving them a

better chance to develop into strong, healthy adults.

**Syphilis-Free Start**

We safeguard the health of pregnant women and their unborn children by enabling access to low-cost syphilis screening and treatment as part of prenatal care. We partner with governments in Liberia, Cameroon, and Zambia to prevent disability, neonatal

mortality, and stillbirths resulting from congenital syphilis. Syphilis-Free Start’s timely detection and treatment prevented 2,300 adverse outcomes such as blindness, neurological issues, and hearing loss between 2021 and 2023, including 1,300 lives saved.



Evidence Action

The END Fund is the only private philanthropic initiative solely dedicated to ending the most common neglected tropical diseases.

Our Mission: To control and eliminate the most prevalent neglected tropical diseases (NTDs) among the world's most vulnerable communities and people by 2030. 


NTDs are a group of parasitic and bacterial diseases largely prevalent in tropical regions that currently receive little attention on the global health agenda yet have a significant impact hampering the potential of individuals and communities at large. The devastating effects of NTDs include irreversible blindness, severe disfigurement, stunted cognitive and physical development, especially in children, malnutrition, social isolation, and more. NTDs also cause 170,000 deaths per year. Their comprehensive impact on all aspects of daily life means that the presence of NTDs costs affected countries billions of dollars per year in lost productivity, out-of-pocket expenses, and reduced socioeconomic and educational attainment. 

Currently, 1.7b individuals are affected by such diseases. However, the treatments and knowledge required to eliminate these diseases are readily available, with the annual cost of treatment per individual averaging 50 cents per year. Demonstrating the uniquely cost-effective impact of NTD treatment, studies have shown treatment is the single most efficient means of improving children’s school attendance and capacity to learn. A recent report by Deloitte on Nigeria showcases the significant gains affected economies stand to make should NTDs be eliminated, with Nigeria’s economy estimated to receive an $18.9b boost from now until 2030. The report is available to view here - https://www2.deloitte.com/za/en/nigeria/pages/strategy/articles/Ending_The_Neglect.html

The END Fund helps ensure those at risk of NTDs need not experience such preventable suffering but can live healthy and prosperous lives instead. We do so by working in close partnership with stakeholders across the global NTD community to identify and fulfill gaps and needs in NTD funding, design programs, strengthen the capacity of local actors, provide technical support, and assist with monitoring and evaluation, amongst various additional activities. Our work helps children stay healthy and in school, prevents advanced cases that cause disability and restrain individuals' productive potential, and alleviates the disproportionate disease burden faced by women and girls, as well as the economic burden of disease on families. We have distributed more than 1.2b treatments since our founding in 2012, with 118m individuals treated in 2021 alone.

We envision living in a world in which all have the opportunity to achieve their full potential, with these diseases that have plagued humans for millennia confined to history once and for all.

The END Fund

Delivering unconditional cash directly to the world's poorest households via secure mobile transfers. 

Since 2009, GiveDirectly has delivered more than $580 million in unconditional cash transfers to families in need. These one-time cash transfers allow recipients to invest in what they need most and have been shown to improve their earnings, children’s school attendance, health, nutrition, and mental well-being.
 
GiveDirectly uses government data to target villages where most or all residents are living in extreme poverty, defined by the World Bank as earning under $2.15/day. In-country GiveDirectly staff enroll one member of each household in the entire village to receive a one-time transfer of about $1,000 USD sent in two installments using mobile money. Recipients can then withdraw the mobile funds as cash with local agents and use the funds to invest in what they need – whether it’s on starting a business, education, making their home safer/sturdier, healthcare, or livestock.
 
GiveDirectly uses rigorous experimental research (randomized controlled trials) to measure the impact of their unconditional cash programs and answer public policy questions, generating evidence on key design and implementation questions across varied contexts. You can find over 300 studies on the positive impacts of cash transfers in GiveDirectly’s Cash Research Explorer.

GiveDirectly

The Albert Schweitzer Foundation works to eliminate cruel farming practices in Germany and to boost the use of plant proteins.

More than 60 billion farm animals are slaughtered every year. Inadequate welfare requirements and legal protections mean that the overwhelming majority of these animals suffer greatly, living their entire lives in crowded, uncomfortable, unhealthy conditions. While recent progress on these issues in Europe is promising, welfare standards in some sectors are still very low. Albert Schweitzer Foundation (ASF) works to raise standards in Germany and in the European Union. ASF also works to boost the use of plant proteins and to reduce the amount of animal products in the supply chains of large buyers such as supermarket chains and catering companies.

The Lobby Register Act (LobbyRG) requires us to disclose the names and places of residence (without specific addresses) of all donors who donate €20,000 or more to us in a calendar year on www.lobbyregister.bundestag.de (site of the German Parliament). If you prefer not to be mentioned, the only option is to donate less than €20,000.

Albert Schweitzer Foundation

Protecting sight and fighting for disability rights

Sightsavers works in more than 30 countries worldwide, focusing on Africa and Asia.
We work with local, regional, national and international partners and governments. With their help, we distribute treatments to prevent disease, carry out eye operations, advocate for disability rights and improve health services to create sustainable development projects. 

Our vision is of a world where avoidable blindness is eliminated, and people with disabilities have the same rights as everyone else. We can only get there thanks to the generosity of our supporters, so we aim to be as transparent as possible so you can be sure your money is being used wisely.

Sightsavers

1435915265

148788709

1766541537

We are a nonprofit, so instead of charging NONPROFIT we rely on the generosity of donors like you.

Choose a donation for Every.org

2074652487

2535103040

2547000601

2869979572